IRIS Institutional Research Information System - OPENBS Open Archive UniBS

CATTINA, FEDERICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.261
EU - Europa 628
AS - Asia 217
OC - Oceania 3
SA - Sud America 3
AF - Africa 1
Totale 2.113
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.252
CN - Cina 146
PL - Polonia 136
UA - Ucraina 128
DE - Germania 119
IT - Italia 92
HK - Hong Kong 36
FI - Finlandia 33
SE - Svezia 30
IE - Irlanda 29
GB - Regno Unito 24
IN - India 18
BE - Belgio 12
FR - Francia 11
RU - Federazione Russa 11
CA - Canada 8
SG - Singapore 8
TR - Turchia 5
AU - Australia 3
BR - Brasile 2
GR - Grecia 2
VN - Vietnam 2
BO - Bolivia 1
JO - Giordania 1
LV - Lettonia 1
MX - Messico 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 2.113
Salva come PNG Salva come JPEG
Città #
Fairfield 166
Warsaw 136
Chandler 115
Jacksonville 95
Ann Arbor 92
Ashburn 90
Woodbridge 88
Houston 87
Seattle 76
Wilmington 71
Cambridge 67
New York 65
Princeton 58
Beijing 57
Hong Kong 36
Helsinki 30
Dublin 29
Brescia 20
Shanghai 18
Des Moines 13
Brussels 12
Jinan 10
Nanjing 10
Pune 10
Dearborn 9
Nanchang 7
San Diego 7
Tianjin 7
San Francisco 6
Guangzhou 5
Rome 5
Shenyang 5
Toronto 5
Haikou 4
Hebei 4
Kocaeli 4
Nürnberg 4
Alzano Lombardo 3
Bologna 3
Brooklyn 3
Changsha 3
Falkenstein 3
Hangzhou 3
Jiaxing 3
Melbourne 3
Milan 3
Ningbo 3
Ancona 2
Casanova Lonati 2
Dong Ket 2
Grafing 2
Leawood 2
Leonberg 2
London 2
Mumbai 2
North York 2
Pescara 2
São Paulo 2
Verona 2
Amman 1
Athens 1
Augusta 1
Boardman 1
Boston 1
Centurion 1
Chicago 1
Chieti 1
Chiswick 1
Darfo 1
Hanover 1
Hillsborough 1
Kunming 1
La Spezia 1
Landshut 1
Lanzhou 1
Lequio Tanaro 1
Los Angeles 1
Mexico City 1
Nanterre 1
New Delhi 1
Norwalk 1
Orange 1
Phoenix 1
Porto 1
Redwood City 1
Riga 1
San Giuliano Milanese 1
Santa Clara 1
Singapore 1
Sucre 1
Taiyuan 1
Venice 1
Wandsworth 1
Westminster 1
Totale 1.612
Salva come PNG Salva come JPEG
Nome #
BACTERIAL BLOOD STREAM INFECTIONS NEGATIVELY IMPACT ON OUTCOME OF PATIENTS TREATED WITH ALLOGENEIC STEM CELL TRANSPLANTATION: 6 YEARS SINGLE-CENTRE EXPERIENCE 225
Targeting HRASV12G Expression to the Zebrafish Early Hemogenic Progenitors Induces a Myeloproliferative Disorder by Repressing the Notch Pathway. 126
EXPRESSION OF TOLL-LIKE RECEPTORS ON PERIPHERAL BLOOD CELLS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: ONGOING RESULTS OF A PROSPECTIVE STUDY. 117
A specific Toll-like receptor profile on T lymphocytes and values of monocytes correlate with bacterial, fungal, and cytomegalovirus infections in the early period of allogeneic stem cell transplantation 116
TARGETING HRASV12G EXPRESSION TO THE ZEBRAFISH EARLY HEMOGENIC PROGENITORS INDUCES A MYELOPROLIFERATIVE DISORDER BY REPRESSING THE NOTCH PATHWAY. 113
Comparative study on ATG-thymoglobulin versus ATG-fresenius for the graft-versus-host disease (GVHD) prophylaxis in allogeneic stem cell transplantation from matched unrelated donor: a single-centre experience over the contemporary years 112
Feasibility of tumor‑derived exosome enrichment in the onco‑hematology leukemic model of chronic myeloid leukemia 112
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS 97
Comparative Somatic Mutational Profiling of CD34+ Hematopoietic Precursors (HSC) and Circulating Endothelial Cells (CEC) in Patients with Primary Myelofibrosis (PMF) 93
Assessment of BCR-ABL1 Transcript Levels By Digital PCR (dPCR) in CML Patients who Achieved a Deep Molecular Response (DMR: MR4.0, MR4.5 And MR5.0) with Tkis May Improve the Detection of Minimal Residual Disease (MRD) and the Selection of Patients for Treatment Free Remission (TFR) 79
Identification of a Novel Mutation Predisposing to Familial AML and MDS Syndrome By a NGS Approach 77
ETV6: A Candidate Gene for Predisposition to “Blend Pedigrees”? A Case Report from the NEXT-Famly Clinical Trial 73
Biological versus Clinical Risk Factors in Acute Myeloid Leukemia: Is There a Winner? 64
ANTI-CMV Immunoglobulins in Association with ANTI-CMV Drugs in Patients with Hematological Malignancies Submitted to Allogeneic STEM CELL Transplantation: A MULTI-Center Retrospective Experience 64
Comparative Study on Fresenius-ATG Versus Thymoglobuline-ATG for the Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Stem Cell Transplantation from Matched Unrelated Donor: A Single Center Experience on 76 Patients 62
Digital PCR (Dpcr) a Step Forward to Detection and Quantification of Minimal Residual Disease (MRD) in Ph+/BCR-ABL1 Chronic Myeloid Leukemia (CML) 59
Safety and Efficacy of ATG-based GvHD prophylaxis in allogeneic stem cell transplantation for acute leukemia and myelodysplastic syndrome: a single center experience 55
Favourable/Intermediate ELN-Risk Acute Myeloid Leukemia to Transplant or Not to Transplant First-Line? 53
DIGITAL PCR IN PH plus CHRONIC MYELOID LEUKEMIA PATIENTS FOR RECOGNITION OF "STABLE" DEEP MOLECULAR RESPONSE AND IDENTIFICATION OF BEST CANDIDATES TO TKI DISCONTINUATION 52
Liposomal doxorubicin for the treatment of iatrogenic kaposi sarcoma following hematopoietic stem cell transplantation 52
ANTI-CMV IMMUNOGLOBULINS IN ASSOCIATION WITH ANTI-CMV DRUGS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES SUBMITTED TO ALLOGENEIC STEM CELL TRANSPLANTATION: A MULTI-CENTRE RETROSPECTIVE EXPERIENCE 48
Incidence and Outcome of Bacterial Blood Stream Infections in Allotransplanted Patients: Rethinking the Role of Fluoroquinolone Prophylaxis 47
EXTRACORPOREAL PHOTOPHERESIS FOR THE TREATEMENT OF ACUTE AND CHRONIC GRAFT VERSUS HOST DISEASE: A RETROSPECTIVE MULTICENTRIC ANALYSIS ON 94 PATIENTS. 47
Allogeneic transplantation for patient with myelodisplastic sindromes: a single centre experience 46
Case Report: Late Onset of Myelodysplastic Syndrome From Donor Progenitor Cells After Allogeneic Stem Cell Transplantation. Which Lessons Can We Draw From the Reported Case? 44
Neurological complications in adult allogeneic hematopoietic stem cell transplant patients: results from a retrospective multicentre study 42
IN VIVO STUDY (MYCEC0617) OF CD34+-HSC AND CEC MUTATIONAL PROFILE FOR INVESTIGATING CELL ORIGIN AND PATHOGENESIS OF PRIMARY MYELOFIBROSIS (PMF) 40
PF404 TUMOR-DERIVED EXOSOMES MAY BE USED AS NEW INFORMATIVE TOOL FOR THE DETECTION OF BONE MARROW RESIDUAL CML LEUKEMIC CELLS ACTIVITY 38
PS997 A NEW BIOMARKER OF RESPONSE TO 5-AZACITIDINE THERAPY IN MDS AND AML PATIENTS: SIRPB1 27
Totale 2.180
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.557
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.557
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201931 0 0 0 0 0 0 0 0 0 0 14 17
2019/2020550 28 11 13 41 38 51 53 49 75 108 32 51
2020/2021514 17 39 14 75 22 69 29 63 45 73 39 29
2021/2022291 23 16 2 27 15 30 12 21 13 51 20 61
2022/2023297 42 13 14 22 24 66 0 33 50 9 14 10
2023/2024277 30 4 40 14 14 103 10 12 49 1 0 0
Totale 2.180